IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 43 filers reported holding IKENA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65 | -33.0% | 15,062 | +1.8% | 0.00% | – |
| Q2 2023 | $97 | -90.3% | 14,800 | +7263.2% | 0.00% | – |
| Q2 2022 | $1,000 | -99.3% | 201 | -99.1% | 0.00% | – |
| Q1 2022 | $135,000 | -21.5% | 22,066 | +61.3% | 0.00% | – |
| Q4 2021 | $172,000 | +75.5% | 13,684 | +75.7% | 0.00% | – |
| Q3 2021 | $98,000 | -9.3% | 7,789 | +1.2% | 0.00% | – |
| Q2 2021 | $108,000 | – | 7,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
| CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
| ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
| Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
| BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
| Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
| Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
| OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
| Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |